发明名称 Nanoparticle contrast agents for diagnostic imaging
摘要 Compositions of nanoparticles functionalized with at least one zwitterionic moiety, methods for making a plurality of nanoparticles, and methods of their use as diagnostic agents are provided. The nanoparticles have characteristics that result in minimal retention of the particles in the body compared to other nanoparticles. The nanoparticle comprising a nanoparticulate transition metal oxide covalently functionalized with a silane-functionalized non-targeting zwitterionic moiety.
申请公布号 US9399075(B2) 申请公布日期 2016.07.26
申请号 US201313872539 申请日期 2013.04.29
申请人 General Electric Company 发明人 Butts Matthew David;Colborn Robert Edgar;Bonitatibus, Jr. Peter John;Torres Andrew Soliz;Bales Brian Christopher;Marino Michael Ernest;Hay Bruce Allan;Kulkarni Amit Mohan
分类号 A61K49/04;C01G35/00;A61K49/00;A61K49/18;B82Y5/00;B82Y30/00 主分类号 A61K49/04
代理机构 代理人 DiConza Paul J.
主权项 1. A composition comprising, a nanoparticle comprising a nanoparticulate transition metal oxide covalently functionalized with a silane-functionalized non-targeting zwitterionic moiety, wherein the nanoparticulate transition metal oxide is directly attached to the silane-functionalized non-targeting zwitterionic moiety without any intervening layer, and wherein the silane-functionalized non-targeting zwitterionic moiety comprises a reaction product of a precursor tri-alkoxy silane, wherein the precursor tri-alkoxy silane is selected from the group consisting of N-((2H-tetrazol-5-yl)methyl)-N,N-dimethyl-3-(trimethoxysilyl)propan-1-aminium, 2-(4-(3-(trimethoxysilyl)propylcarbamoyl)piperazin-1-yl)acetic acid, 3-(4-(3-(trimethoxysilyl)propylcarbamoyl)piperazin-1-yl)propanoic acid, and combinations thereof.
地址 Niskayuna NY US